Zotefoams Directors Increase Shareholdings Through Dividend Reinvestment
Why we think this is neutral
This RNS announcement is a routine notification of directors' transactions, which does not contain any significant business updates or financial information. While it indicates the directors' continued confidence in the company, it does not provide any material news that would significantly impact the investment case.
Key Points
- Directors Ronan Michael Cox and Gary Christopher McGrath purchased additional shares through the Zotefoams Share Incentive Plan dividend reinvestment program
- Cox purchased 6 shares, McGrath purchased 95 shares, both at a price of £3.174 per share
Summary
The specialty chemicals company has announced that two of its directors have purchased additional shares through the dividend reinvestment program.
Zotefoams plc has announced that its Group CEO, Ronan Michael Cox, and Group CFO, Gary Christopher McGrath, have purchased additional ordinary shares in the company through the dividend reinvestment program of the Zotefoams Share Incentive Plan. The directors purchased 6 and 95 shares respectively at a price of £3.174 per share.
DIRECTOR DEALINGS